Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
US-9221812-B2 · Dec 29, 2015 · US
US9975850B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9975850-B2 |
| Application number | US-201715480647-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 6, 2017 |
| Priority date | Apr 8, 2016 |
| Publication date | May 22, 2018 |
| Grant date | May 22, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the preparation of N-(2-(6-fluoro-1H-indol-3-yl)-ethyl)-3-(2,2,3,3-tetrafluoropropoxy)-benzylamine (Compound I), INN-name idalopirdine, and pharmaceutically acceptable salts thereof:
Opening claim text (preview).
The invention claimed is: 1. A process for the preparation of N-(2-(6-fluoro-1H-indol-3-yl)-ethyl)-3-(2,2,3,3 tetrafluoropropoxy)-benzylamine (Compound (I)), and pharmaceutically acceptable salts thereof, comprising the steps of: (1) reacting Compound (III) and Compound (IV) in a solvent or solvent mixture, with or without removal of water, to thereby form a reaction mixture that comprises Compound (V), and (2) reacting the Compound (V) of the reaction mixture formed in step (1) with hydrogen in the presence of a transition metal catalyst in a solvent or a solvent mixture with or without the presence of a first acid to form said Compound (I), and (3) optionally adding a second acid to precipitate said formed Compound (I) as a salt, wherein said Compound (I), Compound (III), Compound (IV) and Compound (V) are: 2. A process according to claim 1 wherein said step (1) further comprises cooling the reaction mixture to precipitate Compound (V) as a solid and Compound (V) is isolated. 3. The process according to claim 1 , wherein Compound (V) is formed in an alcoholic solvent. 4. The process according to claim 3 , wherein said alcoholic solvent is 2-propanol. 5. The process according to claim 1 , wherein Compound (V) is formed in a hydrocarbon solvent. 6. The process according to claim 5 , wherein said hydrocarbon solvent is toluene or heptane or a mixture of toluene and heptane. 7. The process according to claim 1 , wherein water is removed by azeotropical separation in step (1). 8. The process according to claim 1 , wherein the temperature in which Compound (V) is formed is between 0° C. and 100° C. 9. The process according to claim 2 , wherein precipitation of Compound (V) is done by cooling the mixture to between −10° C. and 30° C. 10. The process according to claim 1 , wherein the purity of Compound (III) and Compound (IV) is in the range of 90%-99%. 11. The process according to claim 2 , wherein the hydrogenation is carried out in a solvent comprising an ether, ester, alcohol, hydrocarbon or a solvent mixture consisting of at least two solvents independently selected from an ether, ester, alcohol, or hydrocarbon. 12. The process according to claim 1 , wherein the hydrogenation of Compound (V) is carried out at a hydrogen pressure of 1 bar to 10 bar. 13. The process according to claim 1 , wherein the transition metal catalyst comprises iridium, rhodium, platinum, ruthenium, copper or palladium. 14. The process according to claim 13 , wherein the transition metal catalyst is supported on silicium oxide, alumina, carbon or mixtures thereof. 15. The process according to claim 1 , wherein the hydrogenation is carried out in the presence of the first acid, wherein the first acid is one or more acids selected from the group consisting of acetic acid, methane sulfonic acid, trifluoracetic acid, hydrochloric acid, and sulfuric acid. 16. The process according to claim 1 , wherein Compound (I) is precipitated as a salt by addition of the second acid to obtain the corresponding acid addition salt. 17. The process according to claim 1 , wherein Compound (I) is precipitated as a 1:1 HCl salt. 18. A process for the preparation of Compound (V) comprising the steps of: (a) Mixing Compound (III) and Compound (IV) in a solvent or solvent mixture, with or without azeotropical separation of water to thereby form Compound (V); (b) Precipitating said formed Compound (V); and (c) Isolating the precipitated Compound (V); wherein said Compound (III) and Compound (IV) are:
Azeotropic distillation · CPC title
Tryptamines · CPC title
Radicals substituted by nitrogen atoms, not forming part of a nitro radical · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.